Naltrexone | Pharmacy Online

Tags:

The FDA announced the approval of an new weight loss drug on Sept. 11, 2014. The drug name is Contrave.

Using two separate drugs to shed pounds can be very effective you'll find combinations as you're watching FDA now awaiting approval. When dealing with weight reduction and the those who go through it you should err on the side of caution and allow the FDA do its job and demand some study be done so the public recognizes the side effects and perils associated with the medications before we take them. Keep in mind that drug companies come in business to generate money and that they would say everything to keep people on their own medications.

Researchers discovered that participants taking this drug for a year, lost weight within a month and have kept the body weight off through the 56 weeks from the study. Contrave is often a combination in the drugs naltrexone and bupropion, which appears to reflect a brand new trend of weight-loss drugs that are made up of many active ingredient, which can make them more potent and safer.

Combo-pilling may be the newest fad or even better the newest ahead under scrutiny and so it is just more publicly known although in the past, comb-pilling for weight loss has been around since the eighties. The biggest reason that using a combination of pills has become popular will be the fact that by right now there aren't long term prescription weightloss pills that have been licensed by the FDA apart from orlistat. The truly disturbing part is that doctors are prescribing these combinations of medications even though some of the combinations are actually rejected or have yet to be licensed by the FDA.

Seizures are a side effect with Contrave and really should not be taken in people with seizure disorders. The drug could also raise blood pressure levels and heartbeat, and shouldn't be used in those with a history of cardiac arrest or stroke in the previous six months. Blood pressure and pulse should also be measured before commencing the drug and throughout therapy with the drug.

The FDA also warned that Contrave can raise blood pressure levels and heartbeat and must not be used in patients with uncontrolled high hypertension, and also by a person with heart-related and cerebrovascular (circulation dysfunction impacting the mind) disease. Patients which has a history of heart attack or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded from your clinical trials. Those taking Contrave must have their heart-rate and pulse monitored regularly. In addition, since compound includes bupropion, Contrave comes using a boxed warning to alert physicians and patients for the increased likelihood of suicidal thoughts and behaviors linked to antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for stop smoking.

Approving a drug with this many potentially lethal negative effects is inconsistent with all the mission statement in the FDA. The power from the drug manufacturing lobby is blatantly evident inside the approval of countless drugs requiring 'post-marketing' studies which can be clearly significant to overall drug safety inside US.